CoChat

Telomeropathies: An emerging spectrum disorder

Open access
Holohan, Brody, Wright, Woodring E., Shay, Jerry W. · 2014 · Journal of Cell Biology

The DOI matches its Crossref record; 117 of the 118 references it cites were found in a registry or an index.

Abstract

A constellation of related genetic diseases are caused by defects in the telomere maintenance machinery. These disorders, often referred to as telomeropathies, share symptoms and molecular mechanisms, and mounting evidence indicates they are points along a spectrum of disease. Several new causes of these disorders have been recently discovered, and a number of related syndromes may be unrecognized telomeropathies. Progress in the clinical understanding of telomeropathies has in turn driven progress in the basic science of telomere biology. In addition, the pattern of genetic anticipation in some telomeropathies generates thought-provoking questions about the way telomere length impacts the course of these diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1083/jcb.201401012

Cites

117 of 117 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Molecular biology of telomeropathies. The processes required to correctly replicate and extend telomeres are outlined; genes with known disease-causing mutations are denoted in red. Telomeres are packaged in a “T-loop” configuration characterized by G-strand invasion of the centromere-proximal double-stranded DNA. The T-loop must be dissociated before replication of the telomere can take place, which is accomplished by the RTEL1 helicase. DNA replication after T-loop resolution yields blunt-ended (from leading-strand synthesis) and RNA primer–ended (from lagging strand synthesis) telomere ends, which must be processed by the CST complex (composed of CTC1, STN1, and TEN1) and Apollo before telomerase activity. Telomerase is a complex containing TERT, TERC, and a dimer of the Dyskerin complex (Dyskerin, NOP10, NHP2, GAR1), and its assembly is promoted by TCAB1 in the Cajal body. After assembly, telomerase is localized to the replicated and processed telomere by TCAB1 and TPP1, where it can add 50–100 base pairs of new telomere repeats to the G-overhang. After telomerase activity, the CST complex and DNA polymerase-α perform a fill-in reaction and nucleolytic processing that yields an extended telomere closed to further action by telomerase.
Figure 1. Molecular biology of telomeropathies. The processes required to correctly replicate and extend telomeres are outlined; genes with known disease-causing mutations are denoted in red. Telomeres are packaged in a “T-loop” configuration characterized by G-strand invasion of the centromere-proximal double-stranded DNA. The T-loop must be dissociated before replication of the telomere can take place, which is accomplished by the RTEL1 helicase. DNA replication after T-loop resolution yields blunt-ended (from leading-strand synthesis) and RNA primer–ended (from lagging strand synthesis) telomere ends, which must be processed by the CST complex (composed of CTC1, STN1, and TEN1) and Apollo before telomerase activity. Telomerase is a complex containing TERT, TERC, and a dimer of the Dyskerin complex (Dyskerin, NOP10, NHP2, GAR1), and its assembly is promoted by TCAB1 in the Cajal body. After assembly, telomerase is localized to the replicated and processed telomere by TCAB1 and TPP1, where it can add 50–100 base pairs of new telomere repeats to the G-overhang. After telomerase activity, the CST complex and DNA polymerase-α perform a fill-in reaction and nucleolytic processing that yields an extended telomere closed to further action by telomerase.CC BY-NC-SA · PubMed Central
Figure 2. Three models for the genetic anticipation observed in telomeropathies. Models that explain the anticipation observed in impaired telomere maintenance rely on different assumptions about the behavior of organ-specific stem cells. (A) If lung tissue stem cells have a constant cell division rate that is slower than hematopoietic stem cells during expansion of the multipotent progenitor (MPP) cell compartment but slower than the maintenance HSC division rate after the MPP pool is established, a point will exist in middle age when lung telomere lengths are shorter than MPP/HSC telomere lengths; if the patient started with an initial telomere length sufficient to avoid critically short telomeres until after this point, the patient will experience IPF, whereas patients with initial telomere lengths short enough that they encounter the critical length before that point will experience bone marrow failure. (B) If stem telomere attrition rates are synchronized after development, lung tissue must be subject to an alternative pathological threshold for telomere length that may be age dependent. In this case, patients with longer initial telomere lengths will never encounter critically short telomeres in their bone marrow, while their lung tissue will encounter the alternative threshold, leading to IPF. Patients with shorter initial telomere lengths will encounter critically short telomeres in their bone marrow before the critical threshold for the lungs, leading to bone marrow failure. (C) If telomere attrition rates are synchronous under normal conditions but lung tissue is differentially sensitive to environmental insults, an alternative pathological threshold is not necessary to explain the anticipation. Patients with longer initial telomeres will eventually be driven into IPF by environmental insults while never encountering the critically short telomere length in the HSC compartment, whereas patients with shorter initial telomere length will encounter the critical threshold before insult-driven lung failure. This model is further supported by observations of pulmonary fibrosis after pulmonary toxicity from bone marrow transplant conditioning.
Figure 2. Three models for the genetic anticipation observed in telomeropathies. Models that explain the anticipation observed in impaired telomere maintenance rely on different assumptions about the behavior of organ-specific stem cells. (A) If lung tissue stem cells have a constant cell division rate that is slower than hematopoietic stem cells during expansion of the multipotent progenitor (MPP) cell compartment but slower than the maintenance HSC division rate after the MPP pool is established, a point will exist in middle age when lung telomere lengths are shorter than MPP/HSC telomere lengths; if the patient started with an initial telomere length sufficient to avoid critically short telomeres until after this point, the patient will experience IPF, whereas patients with initial telomere lengths short enough that they encounter the critical length before that point will experience bone marrow failure. (B) If stem telomere attrition rates are synchronized after development, lung tissue must be subject to an alternative pathological threshold for telomere length that may be age dependent. In this case, patients with longer initial telomere lengths will never encounter critically short telomeres in their bone marrow, while their lung tissue will encounter the alternative threshold, leading to IPF. Patients with shorter initial telomere lengths will encounter critically short telomeres in their bone marrow before the critical threshold for the lungs, leading to bone marrow failure. (C) If telomere attrition rates are synchronous under normal conditions but lung tissue is differentially sensitive to environmental insults, an alternative pathological threshold is not necessary to explain the anticipation. Patients with longer initial telomeres will eventually be driven into IPF by environmental insults while never encountering the critically short telomere length in the HSC compartment, whereas patients with shorter initial telomere length will encounter the critical threshold before insult-driven lung failure. This model is further supported by observations of pulmonary fibrosis after pulmonary toxicity from bone marrow transplant conditioning.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Mammalian Telomeres End in a Large Duplex Loop

    Griffith, J. D., Comeau, L., Rosenfield, S., Stansel, R. M., Bianchi, A., Moss, H., & de Lange, T. (1999) · Cell · doi:10.1016/s0092-8674(00)80760-6 · Cited by 2,447 · cited 2×

    “1; Griffith et al., 1999).”
  • Telomerase Catalytic Subunit Homologs from Fission Yeast and Human

    Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256

  • How Shelterin Protects Mammalian Telomeres

    Palm, W., & de Lange, T. (2008) · Annual Review of Genetics · doi:10.1146/annurev.genet.41.110306.130350 · Cited by 1,802 · cited 1×

    “…stem cell; IPF, idiopathic pulmonary fibrosis; POT1, protection of telomeres 1; TERC, telomerase RNA component; TERT, telomerase reverse transcriptase; TIF, telomere-induced foci; TIN2, TRF1-interacting nuclear protein 2; TPP1, TIN2interacting protein 1; TRF, telomere repeat–binding factor.”
  • TERT Promoter Mutations in Familial and Sporadic Melanoma

    Horn, S., Figl, A., Rachakonda, P. S., Fischer, C., Sucker, A., Gast, A., Kadel, S., Moll, I., Nagore, E., Hemminki, K., et al. (2013) · Science · doi:10.1126/science.1230062 · Cited by 1,799 · cited 1×

    “The family suffered from an early-onset melanoma tumor syndrome with multiple co-morbid cancers, including one individual afflicted by six different primary tumors (Horn et al., 2013).”
  • DNA Damage Foci at Dysfunctional Telomeres

    Takai, H., Smogorzewska, A., & de Lange, T. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00542-6 · Cited by 1,409 · cited 2×

    “This progressive shortening eventually interferes with the telomeres’ ability to suppress the DNA damage recognition machinery, triggering telomere-induced foci (TIFs) that lead to a p53/p21-mediated cell growth arrest called replicative senescence (Chin et al., 1999; Takai et al., 2003).”
  • Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis

    Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357 · cited 4×

    “The shelterin complex is composed of six core proteins: telomere repeat–binding factor 1 and 2 (TRF1 and TRF2), TRF1-interacting nuclear protein 2 (TIN2), repressor/activator 291Telomeropathies: An emerging spectrum disorder • Holohan et al. incompletely penetrant phenotypes (Armanios et al., 2007).”
    Influential
  • A telomerase component is defective in the human disease dyskeratosis congenita

    Mitchell, J. R., Wood, E., & Collins, K. (1999) · Nature · doi:10.1038/990141 · Cited by 1,168 · cited 1×

    “Dyskeratosis congenita (DKC) was the first disorder linked to impaired telomere maintenance (Mitchell et al., 1999).”
  • Telomere end-replication problem and cell aging

    Levy, M. Z., Allsopp, R. C., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90096-3 · Cited by 1,069 · cited 2×

    “…synthesis problem and certain less-well defined end replication– processing events, telomeres shorten by 50–100 base pairs per cell division in vitro (Levy et al., 1992; Wu et al., 2012) and 20–30 base pairs per year in peripheral blood mononuclear cells during adulthood, which is modifiable by…”
  • Tankyrase, a Poly(ADP-Ribose) Polymerase at Human Telomeres

    Smith, S., Giriat, I., Schmitt, A., & de Lange, T. (1998) · Science · doi:10.1126/science.282.5393.1484 · Cited by 1,012 · cited 2×

    “In vitro studies have shown direct interactions between FANCD2, telomeric DNA, and tankyrase I (a known regulator of TRF1 binding; Smith et al., 1998), as well as down-regulation of TRF1 in FANCD2 mutant cells (Lyakhovich et al.”
  • The telomere syndromes

    Armanios, M., & Blackburn, E. H. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3246 · Cited by 982 · cited 4×

    “Undiscovered telomeropathies A substantial portion (40%) of DKC has no proven monogenic cause (Armanios and Blackburn, 2012).”
    Influential

Show all 117 references

Cited by

See all 206

Metadata

Authors
Holohan, B., Wright, W. E., & Shay, J. W.
Affiliations
The University of Texas Southwestern Medical Center (US)
Corresponding author
Shay, Jerry W.
Venue
Journal of Cell Biology
Published
2014-05-12
Volume
205
Issue
3
Pages
289-299
ISSN
  • 0021-9525 (ISSN-L)
  • 1540-8140
OpenAlex
W1919832594
Cited by
175
References
118
Citations by year
2026: 3 · 2025: 11 · 2024: 8 · 2023: 10 · 2022: 11 · 2021: 13 · 2020: 9 · 2019: 18 · 2018: 24 · 2017: 24 · 2016: 24 · 2015: 16 · 2014: 4
FWCI
2.66
Type
journal article
Language
en
Open access
Locations
  • The Journal of Cell Biology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
Funders
  • National Institute on Aging (R01AG001228)
  • National Cancer Institute ((P50-CA70907, CA154805, R01CA154805, P50CA070907, P30CA142543)
  • National Center for Research Resources (C06RR030414)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords
telomeropathies, telomere maintenance, telomere biology, genetic anticipation, telomere length, disease spectrum
MeSH terms
Animals, Humans, Neoplasms, Phenotype, Risk Factors, Syndrome, Telomere, Genetic Predisposition to Disease, Genetic Diseases, Inborn, Telomere Homeostasis, Telomere Shortening

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.